Addison Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $147K | Sell |
2,123
-543
| -20% | -$37.5K | 0.04% | 257 |
|
2025
Q1 | $185K | Buy |
2,666
+383
| +17% | +$26.6K | 0.05% | 219 |
|
2024
Q4 | $196K | Sell |
2,283
-424
| -16% | -$36.5K | 0.05% | 208 |
|
2024
Q3 | $322K | Sell |
2,707
-43
| -2% | -$5.12K | 0.09% | 154 |
|
2024
Q2 | $393K | Buy |
2,750
+332
| +14% | +$47.4K | 0.13% | 122 |
|
2024
Q1 | $310K | Buy |
2,418
+87
| +4% | +$11.2K | 0.11% | 139 |
|
2023
Q4 | $241K | Buy |
2,331
+255
| +12% | +$26.4K | 0.09% | 151 |
|
2023
Q3 | $189K | Sell |
2,076
-650
| -24% | -$59.1K | 0.09% | 163 |
|
2023
Q2 | $221K | Buy |
2,726
+56
| +2% | +$4.53K | 0.11% | 141 |
|
2023
Q1 | $212K | Sell |
2,670
-44
| -2% | -$3.5K | 0.12% | 135 |
|
2022
Q4 | $184K | Sell |
2,714
-814
| -23% | -$55.1K | 0.11% | 136 |
|
2022
Q3 | $176K | Buy |
3,528
+36
| +1% | +$1.8K | 0.11% | 129 |
|
2022
Q2 | $195K | Sell |
3,492
-388
| -10% | -$21.7K | 0.12% | 127 |
|
2022
Q1 | $215K | Buy |
3,880
+1,316
| +51% | +$72.9K | 0.12% | 126 |
|
2021
Q4 | $144K | Buy |
2,564
+2,544
| +12,720% | +$143K | 0.09% | 150 |
|
2021
Q3 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 420 |
|